You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大行評級 | 高盛:京東健康近期藥物GMV飆升 予目標價84港元
格隆匯12月20日丨高盛發研報指,日前為京東健康(6618.HK)召開投資者會議,集團管理層提到,過去數週,與新冠相關的藥物和用品的商品成交金額(GMV)出現持續飆升,很大程度上符合該行對線上藥台的預測。該行予“買入”評級,目標價84港元。報吿引述團管理層指,部分城市如廣州和石家莊,11月呼吸機和製氧機等醫療設備銷量呈上升趨勢,而北京等城市近周新冠病例激增,也導致藥品需求增長快於集團的預期。管理層承認,目前主要障礙是個別暢銷類別的庫存短缺,及在疫情快速擴散下人手也出現不足情況,但公司並沒有提高暢銷產品的價格。報吿指,非處方藥物的利潤率可能高於處方藥,認為第四季利潤率表現將趨於正面。管理層重申,目標今年非國際會計準則淨利潤率按年增長1個百分點。該股現報71.5港元,總市值2273億港元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account